Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

PREGNANT women receiving antenatal care at the John Radcliffe Hospital are being invited to take part in a world-first clinical trial.

Visitors to the Women's Centre will be offered a dose of a vaccine that could protect babies from respiratory syncytial virus (RSV) disease in their first months of life.

Some 200,000 children a year are killed by RSV, a lung infection often beginning with a runny nose and cough but leading to serious issues such as bronchitis and asthma.

Read more....